Skip to main content

Abstract

Patients who repeatedly fail to get an appropriate response to platelet transfusions are said to be refractory. Such patients can be highly difficult to manage, particularly when there is an immune cause to the refractoriness. Solve it!

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Khatri SS, Curtis BR, Yamada C. A case of platelet transfusion refractoriness due to anti-CD36 with a successful treatment outcome. Immunohematology. 2019;35(4):139–44.

    Article  PubMed  Google Scholar 

  2. Flesch BK, Scherer V, Opitz A, Ochmann O, Janson A, Steitz M, Zeiler T. Platelet CD36 deficiency is present in 2.6% of Arabian individuals and can cause NAIT and platelet refractoriness. Transfusion. 2021;61(6):1932–42.

    Article  CAS  PubMed  Google Scholar 

  3. The Trial to Reduce Alloimmunization to Platelets Study Group. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N Engl J Med. 1997;337:1861–70.

    Article  Google Scholar 

  4. Cohm CS. Platelet transfusion refractoriness: how do I diagnose and manage? Hematology Am Soc Hematol Educ Program. 2020;2020(1):527–32.

    Article  Google Scholar 

  5. Juskewitch JE, Norgan AP, De Goey SR, Duellman PM, Wakefield LL, Gandhi MJ, et al. How do I…manage the platelet transfusion-refractory patient? Transfusion. 2017;57(12):2828–35.

    Article  CAS  PubMed  Google Scholar 

  6. Lan JH, Kadatz M, Chang DT, Gill J, Gebel HM, Gill JS. Pretransplant calculated panel reactive antibody in the absence of donor-specific antibody and kidney allograft survival. CJASN. 2021;16(2):275–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Kopko PM, Warner P, Kresie L, Pancoska C. Methods for the selection of platelet products for alloimmune-refractory patients. Transfusion. 2015;55(2):235–44.

    Article  CAS  PubMed  Google Scholar 

Further Reading

  • Stroncek DF, Vassallo RR. Platelet and granulocyte antigens and antibodies. In: Cohn CS, Delaney M, Johnson ST, Katz LM, editors. Technical Manual. 20th ed. Bethesda: AABB; 2020. p. 457–73.

    Google Scholar 

  • Juskewitch JE, Norgan AP, De Goey SR, Duellman PM, Wakefield LL, Gandhi MJ, et al. How do I…manage the platelet transfusion-refractory patient? Transfusion. 2017;57(12):2828–35.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mark T. Friedman .

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Friedman, M.T., West, K.A., Bizargity, P., Annen, K., Gur, H.D., Hilbert, T. (2023). Do the Math!. In: Immunohematology, Transfusion Medicine, Hemostasis, and Cellular Therapy. Springer, Cham. https://doi.org/10.1007/978-3-031-14638-1_54

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-14638-1_54

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-14637-4

  • Online ISBN: 978-3-031-14638-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics